Emergingby GlyphCalico and Nexo Therapeutics sign small molecule discovery deal
The companies will jointly pursue Calico-nominated targets for age-related diseases.
Longevity biotechcalicolabs.com
Calico Life Sciences
Large companyUS1 field
Where it works
| Technology | ||
|---|---|---|
| Longevity biotechAlphabet-founded company researching the biology of aging and developing drugs for age-related diseases. | Alphabet-founded company researching the biology of aging and developing drugs for age-related diseases. | calicolabs.com |
Events
AbbVie ends its decade-long partnership with Calico
AbbVie ended the aging research alliance and laid off chemists working on it.
Longevity biotechstatnews.com
Calico licenses Mabwell's IL-11 antibody for age-related disease
Calico gained exclusive rights to IL-11 directed therapeutics including the Phase 1 antibody 9MW3811.
Longevity biotechcalicolabs.com
Calico's fosigotifator misses its goal in the HEALEY ALS platform trial
The eIF2B activator, developed with AbbVie, did not meet the primary endpoint in ALS.
Longevity biotechcalicolabs.com
About
- Source
- calicolabs.com (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
Calico Life Sciences
Joined in Longevity biotech. Alphabet-founded company researching the biology of aging and developing drugs for age-related diseases.
Calico Life Sciences
Added in Longevity biotech. Alphabet-founded company researching the biology of aging and developing drugs for age-related diseases.